Biopharma stocks likely to climb higher after 'blue wave,' analysts say
Analysts expect a friendlier policy backdrop for drugmakers following the election results.
Read at BioPharma Dive →Full coverage · 6 outlets
- BioPharma Dive · lead
- Yahoo FinanceBiopharma likely to climb higher after ‘blue wave,’ analysts say
- ReutersSectors bracing for a pivot as US midterm elections loom
- Barron'sBiotech Stocks: The New Drugs That Could Fuel Big Gains
- The Economic TimesEmcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%
- BiopharmadiveBiopharma likely to climb higher after ‘blue wave,’ analysts say